Đang chuẩn bị liên kết để tải về tài liệu:
Ewing sarcoma with very late metastasis in the skull: A case report

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Ewing sarcoma is a malignant bone tumor; however, its prognosis has improved since the development of modern chemotherapy. Although Ewing sarcoma outcomes have improved, issues related to late complications, secondary malignant neoplasms, and late recurrence or metastasis have emerged. |

TÀI LIỆU LIÊN QUAN

IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells

A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma

Impact of chemotherapy cycles and intervals on outcomes of nonspinal Ewing sarcoma in adults: A real-world experience

A nomogram for determining the diseasespecific survival in Ewing sarcoma: A population study

What is the impact of local control in Ewing sarcoma: Analysis of the first Brazilian collaborative study group – EWING1

Limb saving surgery for Ewing’s sarcoma of the distal tibia: A case report

Up-regulation of GLI1 in vincristine-resistant rhabdomyosarcoma and Ewing sarcoma

NUT carcinoma of the nasal cavity that responded to a chemotherapy regimen for Ewing’s sarcoma family of tumors: A case report

Zoledronic acid inhibits pulmonary metastasis dissemination in a preclinical model of Ewing’s sarcoma via inhibition of cell migration

Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy